HIGHLIGHTS
- who: Bettina Kass from the 2428, Germany have published the article: Au03b2 oligomer concentration in mouse and human brain and its drug-induced reduction exu00a0vivo, in the Journal: (JOURNAL) of May/17,/2022
- what: The authors demonstrate dose- and time-dependent oligomer elimination by the compound RD2 mouse and human AD brain homogenates as sources of native Such ex vivo target engagement analyses with mouse- and human-brain-derived have the potential to enhance the translational value from pre-clinical proof-of-concept studies to clinical trials. The authors demonstrate the usefulness of sFIDA to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.